FindMyKOL
Clinical trialNCT07096297RecruitingPhase 2Interventional

Luspatercept + Darbepoetin in MDS

SponsorYale UniversityEnrollment60MDS (Myelodysplastic Syndrome)
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a single arm open-label Phase II trial of luspatercept and darbepoetin alfa in non-mutated SF3B1 , lower-risk, RBC transfusion dependent MDS participants with an endogenous erythropoietin (EPO) level \< 500 IU/L.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Yale University

    New Haven, Connecticut, United States

    Maximilian Stahl, MD
    Recruiting
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University

    Chicago, Illinois, United States

    Yasmin M Abaza, MD
    Not, yet, recruiting
  • Harold C. Simmons Comprehensive Cancer Center of Ut Southwestern

    Dallas, Texas, United States

    Yazan Madanat, MD
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

DarbeopoetinLuspatercept →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
16 Dec 2025
Primary completion
31 Aug 2030
Completion
31 Aug 2030
Last update posted
23 Mar 2026
Registered enrollment
60
Registry id
NCT07096297
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.